INSANE: Nektar therapeutics | Vintage Vibes

Nektar Therapeutics Stock Rockets 19% on Strong 52-Week Alopecia Areata Data for Lead Drug Candidate

Shares of Nektar Therapeutics surged more than 19% in early Monday trading on April 20, 2026, climbing $16.58 to $101.44 as investors cheered positive 52-week topline results from the Phase 2b REZOLVE-AA clinical trial of the company's lead immunology candidate, rezpegaldesleukin, in patients with severe-to-very-severe alopecia areata.

International Business Times · Apr 20

Why Is Nektar Therapeutics Stock Trading Higher On Thursday? (CORRECTED)

Editor’s Note: This article has been updated to correct an earlier inaccuracy regarding the company’s stock trajectory.

Benzinga · Sep 18, 2025

What's Going On With Nektar Therapeutics Stock On Thursday?

Nektar Therapeutics Inc. (NASDAQ:NKTR) stock traded higher on Thursday, with a session volume of 2.80 million versus the average volume of 1.96 million, according to data from Benzinga Pro.

Benzinga · Sep 4, 2025

Wall Street is Overlooking This Penny Stock, Says Analyst

This penny stock could surge up to 200%, according to one bull, who has high hopes for a pipeline drug ahead of trial data due out in 2025.

Barchart · Oct 4, 2024